These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
150 related articles for article (PubMed ID: 8457385)
1. High levels of 2',5'-oligoadenylate synthetase and 2',5'-oligoadenylate-dependent endonuclease in human trophoblast. Zhang GY; Beltchev B; Fournier A; Zhang YH; Malassiné A; Bisbal C; Ehresmann B; Ehresmann C; Darlix JL; Thang MN AIDS Res Hum Retroviruses; 1993 Feb; 9(2):189-96. PubMed ID: 8457385 [TBL] [Abstract][Full Text] [Related]
2. Basal and interferon-induced 2',5'-oligoadenylate synthetase activity in human placental trophoblast and trophoblast-derived malignant cell lines. Dalsgaard AM; Aboagye-Mathiesen G; Justesen J; Zdravkovic M; Ebbesen P Placenta; 1995 Mar; 16(2):137-46. PubMed ID: 7540757 [TBL] [Abstract][Full Text] [Related]
3. Mode of action of the anti-AIDS compound poly(I).poly(C12U) (Ampligen): activator of 2',5'-oligoadenylate synthetase and double-stranded RNA-dependent kinase. Ushijima H; Rytik PG; Schäcke H; Scheffer U; Müller WE; Schröder HC J Interferon Res; 1993 Apr; 13(2):161-71. PubMed ID: 8099601 [TBL] [Abstract][Full Text] [Related]
4. Upregulation of the 2-5A synthetase/RNase L antiviral pathway associated with chronic fatigue syndrome. Suhadolnik RJ; Reichenbach NL; Hitzges P; Sobol RW; Peterson DL; Henry B; Ablashi DV; Müller WE; Schröder HC; Carter WA Clin Infect Dis; 1994 Jan; 18 Suppl 1():S96-104. PubMed ID: 8148461 [TBL] [Abstract][Full Text] [Related]
5. Evidence for age-dependent impairment of antiviral 2',5'-oligoadenylate synthetase/ribonuclease L-system in tissues of rat. Pfeifer K; Ushijima H; Lorenz B; Müller WE; Schröder HC Mech Ageing Dev; 1993 Feb; 67(1-2):101-14. PubMed ID: 8469023 [TBL] [Abstract][Full Text] [Related]
6. Activation of RNase L is dependent on OAS3 expression during infection with diverse human viruses. Li Y; Banerjee S; Wang Y; Goldstein SA; Dong B; Gaughan C; Silverman RH; Weiss SR Proc Natl Acad Sci U S A; 2016 Feb; 113(8):2241-6. PubMed ID: 26858407 [TBL] [Abstract][Full Text] [Related]
7. The 2-5A system and HIV infection. Schröder HC; Kelve M; Müller WE Prog Mol Subcell Biol; 1994; 14():176-97. PubMed ID: 7914804 [TBL] [Abstract][Full Text] [Related]
8. Activation of the interferon-inducible (2'-5') oligoadenylate synthetase by the Epstein-Barr virus RNA, EBER-1. Sharp TV; Raine DA; Gewert DR; Joshi B; Jagus R; Clemens MJ Virology; 1999 May; 257(2):303-13. PubMed ID: 10329541 [TBL] [Abstract][Full Text] [Related]
9. Lack of 2',5'-oligoadenylate-dependent RNase expression in the human hepatoma cell line HepG2. Tnani M; Bayard BA Biochim Biophys Acta; 1998 Mar; 1402(2):139-50. PubMed ID: 9561800 [TBL] [Abstract][Full Text] [Related]
10. Interferon action: binding of viral RNA to the 40-kilodalton 2'-5'-oligoadenylate synthetase in interferon-treated HeLa cells infected with encephalomyocarditis virus. Gribaudo G; Lembo D; Cavallo G; Landolfo S; Lengyel P J Virol; 1991 Apr; 65(4):1748-57. PubMed ID: 1705989 [TBL] [Abstract][Full Text] [Related]
12. Cleavage of nascent reovirus mRNA by localized activation of the 2'-5'-oligoadenylate-dependent endoribonuclease. Baglioni C; De Benedetti A; Williams GJ J Virol; 1984 Dec; 52(3):865-71. PubMed ID: 6208382 [TBL] [Abstract][Full Text] [Related]
13. Inducible expression of the 2-5A synthetase/RNase L system results in inhibition of vaccinia virus replication. Díaz-Guerra M; Rivas C; Esteban M Virology; 1997 Jan; 227(1):220-8. PubMed ID: 9007077 [TBL] [Abstract][Full Text] [Related]
14. Biochemical evidence for a novel low molecular weight 2-5A-dependent RNase L in chronic fatigue syndrome. Suhadolnik RJ; Peterson DL; O'Brien K; Cheney PR; Herst CV; Reichenbach NL; Kon N; Horvath SE; Iacono KT; Adelson ME; De Meirleir K; De Becker P; Charubala R; Pfleiderer W J Interferon Cytokine Res; 1997 Jul; 17(7):377-85. PubMed ID: 9243369 [TBL] [Abstract][Full Text] [Related]
15. The binding of the 69- and 100-kD forms of 2',5'-oligoadenylate synthetase to different polynucleotides. Marié I; Svab J; Hovanessian AG J Interferon Res; 1990 Dec; 10(6):571-8. PubMed ID: 1707937 [TBL] [Abstract][Full Text] [Related]
16. Protection of HeLa-T4+ cells against human immunodeficiency virus (HIV) infection after stable transfection with HIV LTR-2',5'-oligoadenylate synthetase hybrid gene. Schröder HC; Ugarkovic D; Merz H; Kuchino Y; Okamoto T; Müller WE FASEB J; 1990 Oct; 4(13):3124-30. PubMed ID: 1698680 [TBL] [Abstract][Full Text] [Related]
17. HIV-1 TAR RNA has an intrinsic ability to activate interferon-inducible enzymes. Maitra RK; McMillan NA; Desai S; McSwiggen J; Hovanessian AG; Sen G; Williams BR; Silverman RH Virology; 1994 Nov; 204(2):823-7. PubMed ID: 7524241 [TBL] [Abstract][Full Text] [Related]
18. 8-Azido double-stranded RNA photoaffinity probes. Enzymatic synthesis, characterization, and biological properties of poly(I,8-azidoI).poly(C) and poly(I,8-azidoI).poly(C12U) with 2',5'-oligoadenylate synthetase and protein kinase. Li SW; Moskow JJ; Suhadolnik RJ J Biol Chem; 1990 Apr; 265(10):5470-4. PubMed ID: 2318823 [TBL] [Abstract][Full Text] [Related]
19. RNA drug therapy acting via the 2-5A synthetase/RNase L pathway. Suhadolnik RJ; Reichenbach NL; Hitzges PM; Ablashi DV; Strayer DR; Carter WA Ann N Y Acad Sci; 1993 Jun; 685():756-7. PubMed ID: 8363281 [No Abstract] [Full Text] [Related]
20. Rotavirus Controls Activation of the 2'-5'-Oligoadenylate Synthetase/RNase L Pathway Using at Least Two Distinct Mechanisms. Sánchez-Tacuba L; Rojas M; Arias CF; López S J Virol; 2015 Dec; 89(23):12145-53. PubMed ID: 26401041 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]